Tower Research Capital LLC (Trc) Abbott Laboratories Transaction History

Tower Research Capital LLC (Trc)

$5.8 Billion
Q2 2024

A detailed history of Tower Research Capital LLC (Trc) transactions in Abbott Laboratories stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 118,178 shares of ABT stock, worth $13.3 Million. This represents 0.21% of its overall portfolio holdings.

Number of Shares

118,178

Previous 32,636 262.11%

Holding current value

$13.3 Million

Previous $3.71 Million 231.06%

% of portfolio

0.21%

Previous 0.09%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$100.73 - $112.44 $8.62 Million - $9.62 Million	85,542 Added 262.11%	118,178 $12.3 Million
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $21.1 Million - $23.3 Million	-192,264 Reduced 85.49%	32,636 $3.71 Million
Q4 2023 Feb 13, 2024	BUY	$90.19 - $110.4 $13.9 Million - $17 Million	153,921 Added 216.85%	224,900 $24.8 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $4.52 Million - $5.42 Million	47,300 Added 199.76%	70,979 $6.87 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $458,045 - $510,358	-4,545 Reduced 16.1%	23,679 $2.58 Million
Q1 2023 May 09, 2023	SELL	$96.86 - $114.01 $324,577 - $382,047	-3,351 Reduced 10.61%	28,224 $2.86 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $13.2 Million - $15.5 Million	-138,995 Reduced 81.49%	31,575 $3.47 Million
Q3 2022 Nov 10, 2022	BUY	$96.76 - $112.03 $10 Million - $11.6 Million	103,558 Added 154.54%	170,570 $16.5 Million
Q2 2022 Aug 15, 2022	SELL	$102.07 - $123.37 $18.6 Million - $22.5 Million	-182,674 Reduced 73.16%	67,012 $7.28 Million
Q1 2022 May 12, 2022	BUY	$114.02 - $139.04 $15 Million - $18.3 Million	131,537 Added 111.33%	249,686 $29.6 Million
Q4 2021 Feb 14, 2022	BUY	$115.53 - $141.46 $9.7 Million - $11.9 Million	83,928 Added 245.25%	118,149 $16.6 Million
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $4.32 Million - $4.78 Million	-37,049 Reduced 51.98%	34,221 $4.04 Million
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $7.98 Million - $9.39 Million	-75,409 Reduced 51.41%	71,270 $8.26 Million
Q1 2021 May 17, 2021	BUY	$108.84 - $128.23 $11.4 Million - $13.5 Million	105,074 Added 252.55%	146,679 $17.6 Million
Q4 2020 Feb 16, 2021	BUY	$105.0 - $114.42 $1.12 Million - $1.22 Million	10,640 Added 34.36%	41,605 $4.56 Million
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $903,845 - $1.1 Million	9,863 Added 46.74%	30,965 $3.37 Million
Q2 2020 Aug 13, 2020	BUY	$76.57 - $98.0 $374,274 - $479,024	4,888 Added 30.15%	21,102 $1.93 Million
Q1 2020 May 15, 2020	BUY	$62.82 - $91.86 $1.02 Million - $1.49 Million	16,197 Added 95276.47%	16,214 $1.28 Million
Q4 2019 Feb 07, 2020	SELL	$78.51 - $87.4 $1.93 Million - $2.15 Million	-24,549 Reduced 99.93%	17 $1,000
Q3 2019 Nov 05, 2019	BUY	$81.84 - $88.74 $1.73 Million - $1.88 Million	21,168 Added 622.95%	24,566 $2.06 Million
Q2 2019 Aug 13, 2019	SELL	$72.88 - $85.0 $1.25 Million - $1.45 Million	-17,110 Reduced 83.43%	3,398 $286,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $2.1 Million - $2.54 Million	-31,685 Reduced 60.71%	20,508 $1.64 Million
Q4 2018 Feb 14, 2019	BUY	$65.56 - $74.27 $3.31 Million - $3.75 Million	50,547 Added 3070.9%	52,193 $3.78 Million
Q3 2018 Nov 13, 2018	SELL	$60.81 - $73.36 $4 Million - $4.82 Million	-65,754 Reduced 97.56%	1,646 $121,000
Q2 2018 Aug 15, 2018	BUY	$57.57 - $63.54 $3.32 Million - $3.67 Million	57,736 Added 597.43%	67,400 $4.11 Million
Q1 2018 May 15, 2018	SELL	$56.27 - $63.62 $218,834 - $247,418	-3,889 Reduced 28.69%	9,664 $579,000
Q4 2017 Feb 09, 2018	BUY	$53.68 - $57.47 $383,543 - $410,623	7,145 Added 111.5%	13,553 $773,000
Q3 2017 Nov 14, 2017	BUY	$48.06 - $53.64 $307,968 - $343,725	6,408	6,408 $342,000

Others Institutions Holding ABT

# of Institutions

3,135

Shares Held

1.33B

Call Options Held

8.63M

Put Options Held

7.17M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $197B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account

Tower Research Capital LLC (Trc) Abbott Laboratories Transaction History